Advanced Search

Oncology & Hematology Coding Alert

News Flash:

J9190 and J9395 MUE Issues Should Be Resolved

Published on Tue Apr 12, 2011

Remember to watch for denials that Medicare may overturn on appeal.In last month's issue, Oncology and Hematology Coding Alert covered the problem of fulvestrant claims being denied based on Medically Unlikely Edits (MUEs). An April 1, 2011, update to the MUE files should have solved that problem by increasing the number of units of J9395 (Injection, fulvestrant, 25 mg) that you may report on a single claim-line.If you received MUE-based denials for J9395 for dates of service between Jan. 1, 2011, and March 31, 2011, you may appeal those denials after April 1.Good news: Palmetto GBA and others have indicated that J9190 (Injection, fluorouracil, 500 mg) MUEs were also under review and should have been updated April 1.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All